- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07340528
Endoscopically Assisted Management of Maxillofacial Fractures: A Prospective Study on Efficacy and Outcomes
January 13, 2026 updated by: Elhossieny abdelaal mohamed, Sohag University
The goal of this clinical trial is to assess the efficacy of endoscopically assisted management of maxillofacial fractures in terms of fracture reduction, stability, and functional outcomes.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sohag, Egypt
- Sohag University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
Patients with the following maxillofacial fractures (zygomaticomaxillary complex, orbital floor, mandibular condyle and frontal sinus fracture)
Exclusion Criteria:
- Patients with Severe comminuted fractures requiring extensive open reconstruction
- Patients unfit for intervention medically
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: endoscopic assisted reduction and fixation of maxillofacial fractures
|
using small hidden incisions to approach fractures instead of direct classic approaches
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
rate of facial nerve injury
Time Frame: day 1
|
day 1
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
operating time
Time Frame: periprocedural
|
periprocedural
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2026
Primary Completion (Estimated)
January 15, 2028
Study Completion (Estimated)
January 30, 2028
Study Registration Dates
First Submitted
January 4, 2026
First Submitted That Met QC Criteria
January 13, 2026
First Posted (Actual)
January 14, 2026
Study Record Updates
Last Update Posted (Actual)
January 14, 2026
Last Update Submitted That Met QC Criteria
January 13, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Soh-Med--25-12-4Md
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Time Frame
20 years
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Maxillofacial Injuries
-
Tribhuvan University, NepalUnknownOral and Maxillofacial InjuriesNepal
-
University of California, DavisCompleted
-
Suez Canal UniversitySuez canal university hospitalsNot yet recruitingMaxillofacial Injury | Zygomaticomaxillary Complex Fracture | Facial Bone FractureEgypt
-
Harald EssigEnrolling by invitationTraumatology | Maxillofacial Injuries | Maxillofacial TraumaSwitzerland
-
Indonesia UniversityTerminatedMaxillofacial Injuries | Fracture Fixation, Internal | Maxillofacial Prosthesis ImplantationIndonesia
-
West China HospitalCompletedTherapeutics of Bilateral Maxillofacial InjuriesChina
-
Cairo UniversityNot yet recruiting
-
Global DActive, not recruitingTrauma Injury | Maxillofacial Trauma | Maxilla FractureFrance
-
Medipol UniversityWithdrawnMaxillofacial Abnormalities | Maxillofacial Injuries | Maxillofacial Trauma | Maxillofacial DysostosisTurkey
-
Alexandria UniversityCompleted
Clinical Trials on endoscopy assisted management of maxillofacial fractures
-
University Hospital MuensterTraumaRegister® DGUCompletedRib Fractures | Thorax; FractureGermany
-
University Hospital MuensterCompletedRib Fractures | Rib Fracture Multiple | Rib Trauma | Thorax; FractureGermany
-
Hospices Civils de LyonCompletedBone and Joint Infection | Pseudarthrosis | Open FractureFrance
-
Institute of Liver and Biliary Sciences, IndiaCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Bladder Cancer | Urinary Complications | Stage 0 Bladder Cancer | Stage I Bladder Cancer | Stage II Bladder Cancer
-
Mansoura UniversityUnknownVideo Assisted Anal Fistula TreatmentEgypt
-
Zagazig UniversityCompleted
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingStage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Head and Neck Carcinoma | Lung Carcinoma | Malignant Digestive System NeoplasmUnited States
-
University of Sao Paulo General HospitalUnknownUpper Gastrointestinal Bleeding